Monoethanolamine oleate

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DMacks (talk | contribs) at 15:54, 22 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Ethanolamine Oleate
Clinical data
AHFS/Drugs.comMultum Consumer Information
ATC code
Identifiers
  • 2-Hydroxyethylammonium oleate
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.017.163 Edit this at Wikidata
Chemical and physical data
FormulaC20H41NO3
Molar mass343.552 g·mol−1
Density0.974 g/cm3
 ☒NcheckY (what is this?)  (verify)

Monoethanolamine oleate (properly ethanolammonium oleate) is an antivaricose agent. It is a salt formed by Lowry-Brønsted acid-base reaction between monoethanolamine and oleic acid, is systematically named 2-hydroxyethylammonium (9Z)-octadecenoate, and has a structural formula [CH3(CH2)7CH=CH(CH2)7CO2][H3NCH2CH2OH]. It is injected topically into varicosities to cause sclerosis (closure) of the abnormal vein.

Uses

Ethanolamine Oleate (Ethanolamin) injection is indicated for the treatment of patients with esophageal varices that have recently bled, to prevent rebleeding.

Ethanolamin is not indicated for the treatment of patients with esophageal varices that have not bled. There is no evidence that treatment of this population decreases the likelihood of bleeding.

Sclerotherapy with Ethanolamin has no beneficial effect upon portal hypertension, the cause of esophageal varices, so that recanalization and collateralization may occur, necessitating reinjection.[1]

References

  1. ^ "Ethanolamine Oleate". RXList. Retrieved 7 March 2020.